Antiphospholipid syndrome: obstetric diagnosis, management, and controversies.
about
Fetal exposure to nonsteroidal anti-inflammatory drugs and spontaneous abortionsAnti-inflammatory pharmacotherapy during pregnancyAspirin desensitization in the treatment of antiphospholipid syndrome during pregnancy in ASA-sensitive patientsRelated factors of fetal loss in Chinese women with systemic lupus erythematosus: data from Chinese SLE Treatment and Research Group registry IV.Neonatal outcome in pregnant patients with antiphospholipid syndrome.Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital datasetUterine CD56dim and CD16+ Cells in Refractory Antiphospholipid Antibody-Related Pregnancy Loss and Chromosomally Intact Abortuses: A Case-Control Study.Aspirin and heparin effect on basal and antiphospholipid antibody modulation of trophoblast function.Antiphospholipid antibody tests: spreading the netAntiphospholipid Syndrome during pregnancy: the state of the artUpdate on systemic lupus erythematosus pregnancyAntiphospholipid (Hughes) syndrome.Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases.Prenatal screening for thrombophilia: the background and the approach.Diagnosis of antiphospholipid syndrome.The management of rheumatic diseases in pregnancyPersistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes.Pregnancy outcomes of antiphospholipid syndrome: In a low resource South Asian settingAntiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway.Aspirin: The Mechanism of Action Revisited in the Context of Pregnancy Complications.Immunologic characteristics of preeclampsia, a comprehensive review.Management of obstetric antiphospholipid syndrome.Reproduction and autoimmune disease: important translational implications from embryo-maternal interaction.Pregnancy outcomes in patients with systemic lupus erythematosus: a retrospective review of 62 pregnancies at a single tertiary center in South Korea.High-risk pregnancy and the rheumatologist.Vitamin D reverses aPL-induced inflammation and LMWH-induced sFlt-1 release by human trophoblast.Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function.Pravastatin does not prevent antiphospholipid antibody-mediated changes in human first trimester trophoblast function.Combined screening for preeclampsia and small for gestational age at 11-13 weeks.Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology.Low molecular weight heparin and aspirin exacerbate human endometrial endothelial cell responses to antiphospholipid antibodies.Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparin.Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss.Maternal and fetal outcome in women with antiphospholipid syndrome: a three-year observational study.
P2860
Q24568175-8ED6DEF7-6581-440B-A2E0-03D28201A8D8Q28167716-5738DD71-CAC3-4AB9-8153-03C72E1211C1Q28194016-6322F3E0-5A7A-4FA5-A505-79FE25ED5F5EQ30882151-83C4AEE0-EF83-4337-A984-8BB250FF85BFQ33418245-99D61560-C607-4642-AF37-453BFFE4D56DQ33418783-821F2974-605A-4993-9B2D-1A9747E6A05DQ33604941-0C658FEA-2E53-4082-A197-0EB52C045841Q35419081-6DB6054B-EBE7-47D1-99F2-318B610F9A1BQ35554909-D19C5212-0D5A-4BDD-A5B3-8D331FD29B8BQ35756040-EA7C9D47-90CD-4D75-9DDD-E5B7D8BB0B78Q35756117-1DCA2C8A-55D7-4D7B-9743-480943DDFC59Q35934717-6B9D628C-88D9-49A3-9E59-914690A25D66Q35953379-01FC55C5-BCB9-43CA-BA98-DEC5020DA738Q36030393-70F6DAF7-DAEE-40B1-B367-1EFC881A848FQ36577371-F0875877-FDD8-4697-A74B-5D4AAB9A8F95Q37047839-7A6359E2-E40C-4DD1-A906-7F46DEDA6641Q37090069-78F72606-12D5-4E89-91BA-9784D21E98B8Q37107290-9C76F060-A34E-4790-8C93-C8581229650DQ37409260-E3C23A24-E44E-4328-9F9C-8B44B90876D5Q37699576-4DA15BAD-AE47-4FC0-A74E-6626F3E7DFEAQ37786350-2141C2FE-A5AE-4D19-903C-14E88040CE41Q37959314-978BC779-0598-4609-B49D-582A6B2860FFQ38119553-A837AE76-9516-4D6E-9802-8BA00EF82B3CQ38255384-040A3436-0E0A-4316-B094-2EC78DAA8F59Q38283472-0982BB5E-EB97-43CF-9842-96109999FC48Q38970808-89BB6AE5-18E8-48DB-8E76-C0E71F8E1CF7Q39044818-867EC10A-C97F-4575-96BB-8C281FD2D351Q39298598-691C3347-8956-4955-8FAC-D3CCEFCEB686Q43823700-571BBB32-65C0-41D6-BF69-98ABBE9B3509Q46396909-60ABDE44-A263-4E26-AA6E-FAB5DC604CF1Q47176561-5D1E1C18-4E73-46D1-9041-DC32B2B08FACQ53250090-067050EF-A326-401E-A327-89240FDCD490Q53560316-1192DD88-9AF6-45B5-A25B-E2FA80A06FE9Q53773313-A94E386E-8701-48F2-8A06-8E35D7DF55C3
P2860
Antiphospholipid syndrome: obstetric diagnosis, management, and controversies.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Antiphospholipid syndrome: obstetric diagnosis, management, and controversies.
@ast
Antiphospholipid syndrome: obstetric diagnosis, management, and controversies.
@en
type
label
Antiphospholipid syndrome: obstetric diagnosis, management, and controversies.
@ast
Antiphospholipid syndrome: obstetric diagnosis, management, and controversies.
@en
prefLabel
Antiphospholipid syndrome: obstetric diagnosis, management, and controversies.
@ast
Antiphospholipid syndrome: obstetric diagnosis, management, and controversies.
@en
P1476
Antiphospholipid syndrome: obstetric diagnosis, management, and controversies.
@en
P2093
D Ware Branch
P304
P356
10.1016/S0029-7844(03)00363-6
P407
P577
2003-06-01T00:00:00Z